Short answer · Medically reviewed summary · Last updated: 2026-04-07
Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder characterized by distinctive facial features, growth delays, and developmental differences that affect multiple body systems. While the clinical presentation varies widely among individuals, it is primarily caused by mutations in genes responsible for the cohesin complex, which is essential for proper cell division and gene regulation. What are the primary characteristics of Cornelia de Lange Syndrome? Cornelia de Lange Syndrome is a multisystem condition that impacts many aspects of physical and cognitive development.
Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder characterized by distinctive facial features, growth delays, and developmental differences that affect multiple body systems. While the clinical presentation varies widely among individuals, it is primarily caused by mutations in genes responsible for the cohesin complex, which is essential for proper cell division and gene regulation.
Cornelia de Lange Syndrome is a multisystem condition that impacts many aspects of physical and cognitive development. Individuals with Cornelia de Lange Syndrome often present with a recognizable facial appearance, including arched eyebrows that meet in the middle (synophrys), long eyelashes, a short nose with upturned nostrils, and a thin upper lip. Beyond physical appearance, the syndrome commonly affects the growth, skeletal, and gastrointestinal systems. Many children with Cornelia de Lange Syndrome experience significant developmental delays, ranging from mild to severe, and may have challenges with communication and social interaction.
The clinical impact of Cornelia de Lange Syndrome is highly variable, meaning no two individuals have the exact same experience. Common systemic issues include:
Cornelia de Lange Syndrome is considered a rare disease, with an estimated prevalence ranging from 1 in 10,000 to 1 in 30,000 live births. Because mild cases may go undiagnosed or be misidentified, these numbers are estimates. The condition affects males and females equally, and it has been identified in populations across all geographic regions and ethnic backgrounds.
At the molecular level, Cornelia de Lange Syndrome is caused by a disruption in the cohesin complex. This complex acts like "molecular glue" that holds DNA together during cell division and helps regulate how genes are turned on or off. Most cases are caused by a "de novo" mutation, meaning the genetic change happens spontaneously in the individual and is not inherited from either parent. However, in some instances, the condition can be passed down in an autosomal dominant or X-linked pattern. Currently, 133 people with Cornelia de Lange Syndrome have joined the DiseaseMaps community to share their experiences and support one another.
While some genetic syndromes share features like growth delays or developmental challenges, the specific combination of facial features, limb differences, and the underlying genetic involvement of the cohesin complex makes Cornelia de Lange Syndrome clinically distinct. A diagnosis is typically confirmed through genetic testing that identifies a pathogenic variant in genes such as NIPBL, SMC1A, or SMC3.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.